Betahistine Hydrochloride - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512240659

Publication Date:

December 11, 2024

Pages:

123

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Betahistine Hydrochloride was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Betahistine Hydrochloride was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Betahistine Hydrochloride was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Betahistine Hydrochloride was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Betahistine Hydrochloride include Disphar International BV, DOC Generici, Nichi-Iko Pharmaceutical, Enal Drugs Pvt, TOWA PHARMACEUTICAL, Ami Lifesciences, EA Pharma, Jinzhou Jiutai Pharmaceutical and Henan Puri Pharmaceutical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Betahistine Hydrochloride, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Betahistine Hydrochloride by region & country, by Type, and by Application.
The Betahistine Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Betahistine Hydrochloride.
Market Segmentation
By Company
Disphar International BV
DOC Generici
Nichi-Iko Pharmaceutical
Enal Drugs Pvt
TOWA PHARMACEUTICAL
Ami Lifesciences
EA Pharma
Jinzhou Jiutai Pharmaceutical
Henan Puri Pharmaceutical
Zhejiang Lepu Pharmaceutical
Segment by Type:
Betagluptine Hydrochloride Tablets
Betagluptine Hydrochloride Injection
Other
Segment by Application
Meniere's Syndrome
Cerebral Arteriosclerosis
Cerebral Thrombosis
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Betahistine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Betahistine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Betahistine Hydrochloride in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Betahistine Hydrochloride Product Introduction
1.2 Global Betahistine Hydrochloride Market Size Forecast
1.2.1 Global Betahistine Hydrochloride Sales Value (2019-2030)
1.2.2 Global Betahistine Hydrochloride Sales Volume (2019-2030)
1.2.3 Global Betahistine Hydrochloride Sales Price (2019-2030)
1.3 Betahistine Hydrochloride Market Trends & Drivers
1.3.1 Betahistine Hydrochloride Industry Trends
1.3.2 Betahistine Hydrochloride Market Drivers & Opportunity
1.3.3 Betahistine Hydrochloride Market Challenges
1.3.4 Betahistine Hydrochloride Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Betahistine Hydrochloride Players Revenue Ranking (2023)
2.2 Global Betahistine Hydrochloride Revenue by Company (2019-2024)
2.3 Global Betahistine Hydrochloride Players Sales Volume Ranking (2023)
2.4 Global Betahistine Hydrochloride Sales Volume by Company Players (2019-2024)
2.5 Global Betahistine Hydrochloride Average Price by Company (2019-2024)
2.6 Key Manufacturers Betahistine Hydrochloride Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Betahistine Hydrochloride Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Betahistine Hydrochloride
2.9 Betahistine Hydrochloride Market Competitive Analysis
2.9.1 Betahistine Hydrochloride Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Betahistine Hydrochloride Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Betahistine Hydrochloride as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Betagluptine Hydrochloride Tablets
3.1.2 Betagluptine Hydrochloride Injection
3.1.3 Other
3.2 Global Betahistine Hydrochloride Sales Value by Type
3.2.1 Global Betahistine Hydrochloride Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Betahistine Hydrochloride Sales Value, by Type (2019-2030)
3.2.3 Global Betahistine Hydrochloride Sales Value, by Type (%) (2019-2030)
3.3 Global Betahistine Hydrochloride Sales Volume by Type
3.3.1 Global Betahistine Hydrochloride Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Betahistine Hydrochloride Sales Volume, by Type (2019-2030)
3.3.3 Global Betahistine Hydrochloride Sales Volume, by Type (%) (2019-2030)
3.4 Global Betahistine Hydrochloride Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Meniere's Syndrome
4.1.2 Cerebral Arteriosclerosis
4.1.3 Cerebral Thrombosis
4.1.4 Other
4.2 Global Betahistine Hydrochloride Sales Value by Application
4.2.1 Global Betahistine Hydrochloride Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Betahistine Hydrochloride Sales Value, by Application (2019-2030)
4.2.3 Global Betahistine Hydrochloride Sales Value, by Application (%) (2019-2030)
4.3 Global Betahistine Hydrochloride Sales Volume by Application
4.3.1 Global Betahistine Hydrochloride Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Betahistine Hydrochloride Sales Volume, by Application (2019-2030)
4.3.3 Global Betahistine Hydrochloride Sales Volume, by Application (%) (2019-2030)
4.4 Global Betahistine Hydrochloride Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Betahistine Hydrochloride Sales Value by Region
5.1.1 Global Betahistine Hydrochloride Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Betahistine Hydrochloride Sales Value by Region (2019-2024)
5.1.3 Global Betahistine Hydrochloride Sales Value by Region (2025-2030)
5.1.4 Global Betahistine Hydrochloride Sales Value by Region (%), (2019-2030)
5.2 Global Betahistine Hydrochloride Sales Volume by Region
5.2.1 Global Betahistine Hydrochloride Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Betahistine Hydrochloride Sales Volume by Region (2019-2024)
5.2.3 Global Betahistine Hydrochloride Sales Volume by Region (2025-2030)
5.2.4 Global Betahistine Hydrochloride Sales Volume by Region (%), (2019-2030)
5.3 Global Betahistine Hydrochloride Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Betahistine Hydrochloride Sales Value, 2019-2030
5.4.2 North America Betahistine Hydrochloride Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Betahistine Hydrochloride Sales Value, 2019-2030
5.5.2 Europe Betahistine Hydrochloride Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Betahistine Hydrochloride Sales Value, 2019-2030
5.6.2 Asia Pacific Betahistine Hydrochloride Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Betahistine Hydrochloride Sales Value, 2019-2030
5.7.2 South America Betahistine Hydrochloride Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Betahistine Hydrochloride Sales Value, 2019-2030
5.8.2 Middle East & Africa Betahistine Hydrochloride Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Betahistine Hydrochloride Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Betahistine Hydrochloride Sales Value
6.2.1 Key Countries/Regions Betahistine Hydrochloride Sales Value, 2019-2030
6.2.2 Key Countries/Regions Betahistine Hydrochloride Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Betahistine Hydrochloride Sales Value, 2019-2030
6.3.2 United States Betahistine Hydrochloride Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Betahistine Hydrochloride Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Betahistine Hydrochloride Sales Value, 2019-2030
6.4.2 Europe Betahistine Hydrochloride Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Betahistine Hydrochloride Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Betahistine Hydrochloride Sales Value, 2019-2030
6.5.2 China Betahistine Hydrochloride Sales Value by Type (%), 2023 VS 2030
6.5.3 China Betahistine Hydrochloride Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Betahistine Hydrochloride Sales Value, 2019-2030
6.6.2 Japan Betahistine Hydrochloride Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Betahistine Hydrochloride Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Betahistine Hydrochloride Sales Value, 2019-2030
6.7.2 South Korea Betahistine Hydrochloride Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Betahistine Hydrochloride Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Betahistine Hydrochloride Sales Value, 2019-2030
6.8.2 Southeast Asia Betahistine Hydrochloride Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Betahistine Hydrochloride Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Betahistine Hydrochloride Sales Value, 2019-2030
6.9.2 India Betahistine Hydrochloride Sales Value by Type (%), 2023 VS 2030
6.9.3 India Betahistine Hydrochloride Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Disphar International BV
7.1.1 Disphar International BV Company Information
7.1.2 Disphar International BV Introduction and Business Overview
7.1.3 Disphar International BV Betahistine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Disphar International BV Betahistine Hydrochloride Product Offerings
7.1.5 Disphar International BV Recent Development
7.2 DOC Generici
7.2.1 DOC Generici Company Information
7.2.2 DOC Generici Introduction and Business Overview
7.2.3 DOC Generici Betahistine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
7.2.4 DOC Generici Betahistine Hydrochloride Product Offerings
7.2.5 DOC Generici Recent Development
7.3 Nichi-Iko Pharmaceutical
7.3.1 Nichi-Iko Pharmaceutical Company Information
7.3.2 Nichi-Iko Pharmaceutical Introduction and Business Overview
7.3.3 Nichi-Iko Pharmaceutical Betahistine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Nichi-Iko Pharmaceutical Betahistine Hydrochloride Product Offerings
7.3.5 Nichi-Iko Pharmaceutical Recent Development
7.4 Enal Drugs Pvt
7.4.1 Enal Drugs Pvt Company Information
7.4.2 Enal Drugs Pvt Introduction and Business Overview
7.4.3 Enal Drugs Pvt Betahistine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Enal Drugs Pvt Betahistine Hydrochloride Product Offerings
7.4.5 Enal Drugs Pvt Recent Development
7.5 TOWA PHARMACEUTICAL
7.5.1 TOWA PHARMACEUTICAL Company Information
7.5.2 TOWA PHARMACEUTICAL Introduction and Business Overview
7.5.3 TOWA PHARMACEUTICAL Betahistine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
7.5.4 TOWA PHARMACEUTICAL Betahistine Hydrochloride Product Offerings
7.5.5 TOWA PHARMACEUTICAL Recent Development
7.6 Ami Lifesciences
7.6.1 Ami Lifesciences Company Information
7.6.2 Ami Lifesciences Introduction and Business Overview
7.6.3 Ami Lifesciences Betahistine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Ami Lifesciences Betahistine Hydrochloride Product Offerings
7.6.5 Ami Lifesciences Recent Development
7.7 EA Pharma
7.7.1 EA Pharma Company Information
7.7.2 EA Pharma Introduction and Business Overview
7.7.3 EA Pharma Betahistine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
7.7.4 EA Pharma Betahistine Hydrochloride Product Offerings
7.7.5 EA Pharma Recent Development
7.8 Jinzhou Jiutai Pharmaceutical
7.8.1 Jinzhou Jiutai Pharmaceutical Company Information
7.8.2 Jinzhou Jiutai Pharmaceutical Introduction and Business Overview
7.8.3 Jinzhou Jiutai Pharmaceutical Betahistine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Jinzhou Jiutai Pharmaceutical Betahistine Hydrochloride Product Offerings
7.8.5 Jinzhou Jiutai Pharmaceutical Recent Development
7.9 Henan Puri Pharmaceutical
7.9.1 Henan Puri Pharmaceutical Company Information
7.9.2 Henan Puri Pharmaceutical Introduction and Business Overview
7.9.3 Henan Puri Pharmaceutical Betahistine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Henan Puri Pharmaceutical Betahistine Hydrochloride Product Offerings
7.9.5 Henan Puri Pharmaceutical Recent Development
7.10 Zhejiang Lepu Pharmaceutical
7.10.1 Zhejiang Lepu Pharmaceutical Company Information
7.10.2 Zhejiang Lepu Pharmaceutical Introduction and Business Overview
7.10.3 Zhejiang Lepu Pharmaceutical Betahistine Hydrochloride Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Zhejiang Lepu Pharmaceutical Betahistine Hydrochloride Product Offerings
7.10.5 Zhejiang Lepu Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Betahistine Hydrochloride Industrial Chain
8.2 Betahistine Hydrochloride Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Betahistine Hydrochloride Sales Model
8.5.2 Sales Channel
8.5.3 Betahistine Hydrochloride Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Disphar International BV
DOC Generici
Nichi-Iko Pharmaceutical
Enal Drugs Pvt
TOWA PHARMACEUTICAL
Ami Lifesciences
EA Pharma
Jinzhou Jiutai Pharmaceutical
Henan Puri Pharmaceutical
Zhejiang Lepu Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂